A Blood Test That Could Change How We Spot Disease

Scientists have developed a blood test that might flag multiple cancers and other illnesses early, without breaking the bank. Instead of searching for specific disease markers, this test looks at tiny chemical tags on DNA, called methyl groups, that float around in your bloodstream. These tags act like labels, showing which cells they came from and whether they’re healthy or not. Every day, billions of cells die and release their DNA into the blood, giving doctors a snapshot of what’s happening inside your body. The test, called MethylScan, focuses on where these chemical tags attach to DNA—a process called methylation. Cancer and other diseases mess with these tags, changing their patterns. The challenge? Most DNA in your blood actually comes from healthy blood cells, not from organs that might be sick. Researchers had to find a way to filter out the noise, so they designed a method to ignore the irrelevant DNA and zero in on the clues that matter.In a study, scientists tested MethylScan on over 1, 000 people, including those with liver, lung, ovarian, and stomach cancers, as well as liver diseases like hepatitis and fatty liver. The results were promising. The test correctly spotted about 63% of all cancers and 55% of early-stage cases, with very few false alarms. For liver cancer, it worked even better, catching nearly 80% of cases while keeping errors low. It could also tell different liver diseases apart, getting it right about 85% of the time. One big advantage is that the test doesn’t just say “something’s wrong”—it can hint at where the problem is. That’s key because a positive result would still need follow-up tests like scans to pinpoint the issue. Without this, doctors might waste time checking the wrong places. Right now, the test isn’t ready for widespread use, but it’s a step toward simpler, more universal screening. Not everyone is convinced, though. Some experts wonder how well this would work in real-world settings, where people have all kinds of conditions. Others point out that even with high accuracy, early detection doesn’t always mean better survival. Still, the idea of a single test catching multiple diseases at once is a game-changer.